Pages

Wednesday, 22 September 2021

Warren Buffett Offer the Best Advice You Will Hear Today

 It Took Warren Buffett 2 Sentences to Offer the Best Advice You Will Hear Today


Marcel Schwantes 23 hrs ago


Timeless wisdom from the Oracle of Omaha.

It was 2004 and Warren Buffett was fielding questions from people in the audience at the Berkshire Hathaway annual meeting in Omaha, Nebraska.

Teenager Justin Fong from California asked the billionaire Buffett what advice he would give a young person on how to be successful.

Buffett said:

It's better to hang out with people better than you. Pick out associates whose behavior is better than yours and you'll drift in that direction.

Buffett taught a life lesson for all of us about absorbing the very qualities and traits of successful people who will elevate us and make us better as leaders, workers, and human beings.

Video: How Warren Buffett Built His Wealth (TheStreet)

--
Current Time 0:02
Duration 1:07
Loaded53.35%
0
How Warren Buffett Built His Wealth

Surround yourself with better and smarter people

The people you choose to be around truly matter for your career progression. When you choose to surround yourself with better and smarter individuals and learn from their success habits, you absorb their knowledge and become better and smarter yourself.

When thinking about taking Buffett's advice to better ourselves, the first step is to consciously choose to engage people further along the path so you can pick up their positive habits of success.

Here are three types of people to surround yourself with today.

1. People with character

People operating with character and integrity can be trusted; you never have to worry about their actions, or whether they're hiding anything from anyone. A person with character brings more truth and truth-tellers to the business, which makes it very attractive to those seeking honest brands. A culture of character differentiates itself from the rest and is the core and essence of any great company.

2. People who live by their values

Successful people have an unwavering commitment to living their values and often measure their success by them. This is especially the case when life throws them a curveball and things get dicey. Through thick and thin, they stick with their values because their values define who they are and what their core business and mission are about in order to best serve others.

3. People who are legitimately loved by others.

As depicted in Buffett's biography, The Snowball: Warren Buffett and the Business of Life, Buffett once was asked about his greatest success and greatest failure, to which he responded: "When you get to my age, you'll really measure your success in life by how many of the people you want to have love you actually do love you." He added, "I know people who have a lot of money ... but the truth is that nobody in the world loves them. That's the ultimate test of how you have lived your life."

https://www.msn.com/en-us/money/smallbusiness/it-took-warren-buffett-2-sentences-to-offer-the-best-advice-you-will-hear-today/ar-AAOFc0l

Sunday, 19 September 2021

Ivermectin articles on this blog so far

 



  1. aspirin - to reduce micro clots in the lungs,
  2. cholcicine - used for treatment of gout to prevent micro clots in the blood vessels in the lungs,
  3. favipiravir - an anti-viral,
  4. dexamethasone - a steroid used for almost 80 years, to control 'cytokine storm'

COVID-19: Life-saving antibody treatment to be rolled out across UK from next week

Ronapreve, an antibody cocktail developed by Roche and Regeneron, will be initially used to treat COVID-19 hospital patients who have not developed an adequate antibody response.

The government said it has secured enough supply of the new therapeutic treatment for NHS patients across the four nations. File pic

A new antibody treatment for COVID-19 will be rolled out to NHS patients across the UK from next week, the government has announced.

Ronapreve, an antibody cocktail developed by Roche and Regeneron, will be initially used to treat COVID-19 hospital patients who have not developed an adequate antibody response.

It will be provided to those without antibodies who are aged 50 and over, or those aged 12 to 49 who are immunocompromised, including people with some types of cancer or autoimmune diseases.

Former US president Donald Trump was treated with Ronapreve when he was ill with COVID-19

The drug, which was taken by then-US president Donald Trump when he had COVID-19, has been shown to reduce hospital stays by four days and the risk of death by a fifth.

The government said it has secured enough supply of the new therapeutic treatment for NHS patients across the four nations, with plans to begin treating eligible hospital patients from next week.


Antibody testing will be used to determine whether patients are seronegative, meaning they do not have an adequate existing antibody response and could therefore benefit from the medicine.

Ronapreve was the first antibody treatment to be approved by the Medicines and Healthcare products Regulatory Agency (MHRA) for the prevention and treatment of COVID-19 infections in the UK.

Health Secretary Sajid Javid said: "We have secured a brand new treatment for our most vulnerable patients in hospitals across the UK and I am thrilled it will be saving lives from as early as next week.

"The UK is leading the world in identifying and rolling out life-saving medicines, particularly for COVID-19, and we will continue our vital work to find the best treatments available to save lives and protect the NHS."

UK COVID-19 antibody testing programme: How will it work?

UK COVID-19 antibody testing programme: How will it work?

The drug, a combination of two monoclonal antibodies called casirivimab and imdevimab, will be administered through a drip and works by binding to the virus' spike protein, preventing it from being able to infect the body's cells.

Monoclonal antibodies are man-made antibodies that act like natural antibodies in the immune system.

The Department of Health said clinicians will soon receive guidance so they can start prescribing the treatment.

The MHRA said in August that the clinical trial data it assessed showed that Ronapreve can be used to prevent COVID-19, treat serious infections, and lower the chances of hospital admission.

The trials were conducted before widespread COVID-19 vaccination and before the emergence of variants.

Most people develop COVID-19 antibodies from vaccination or exposure to the virus.

 https://news.sky.com/story/covid-19-life-saving-antibody-treatment-to-be-rolled-out-across-uk-from-next-week-12410623


ALSO:

https://healthticket.blogspot.com/2021/09/covid-19-life-saving-antibody-treatment.html

https://healthticket.blogspot.com/2021/08/immune-boosting-drugs-to-protect-one-in.html

https://healthticket.blogspot.com/2021/09/ronapreve-most-vulnerable-to-get-new.html